Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.34 USD
Change Today -0.03 / -0.47%
Volume 251.6K
FCSC On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 5:20 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

fibrocell science inc (FCSC) Snapshot

Open
$6.35
Previous Close
$6.37
Day High
$6.45
Day Low
$6.10
52 Week High
07/23/15 - $6.85
52 Week Low
12/15/14 - $2.28
Market Cap
275.8M
Average Volume 10 Days
489.1K
EPS TTM
$-0.53
Shares Outstanding
43.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FIBROCELL SCIENCE INC (FCSC)

fibrocell science inc (FCSC) Related Bloomberg News

View More Bloomberg News

fibrocell science inc (FCSC) Related Businessweek News

No Related Businessweek News Found

fibrocell science inc (FCSC) Details

Fibrocell Science, Inc., an autologous cell therapy company, focuses on developing treatments for skin and connective tissue diseases with unmet medical needs. The company, through its proprietary autologous fibroblast technology, develops azficel-T, which is in Phase II clinical trials for the treatment of vocal cord scarring and restrictive burn scarring. It is also conducting orphan gene therapy program that is in pre-clinical development stage for the treatment of recessive dystrophic epidermolysis bullosa; and gene therapy program, which is in pre-clinical development stage for linear scleroderma. The company has collaboration agreement with Intrexon Corporation for using genetically-modified autologous fibroblast cells to target proteins in patients with rare genetic skin and connective tissue disorders; and University of California, Los Angeles to focus on discoveries and technologies related to stem cells and regenerative cells in human skin. The company was formerly known as Isolagen, Inc. and changed its name to Fibrocell Science, Inc. in September 2009. Fibrocell Science, Inc. was founded in 1995 and is headquartered in Exton, Pennsylvania.

50 Employees
Last Reported Date: 03/13/15
Founded in 1995

fibrocell science inc (FCSC) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $490.0K
Controller
Total Annual Compensation: $204.5K
Vice President of Scientific Affairs
Total Annual Compensation: $287.6K
Vice President of Quality
Total Annual Compensation: $148.8K
Compensation as of Fiscal Year 2014.

fibrocell science inc (FCSC) Key Developments

Fibrocell Science, Inc. Submits an Investigation New Drug Application with the U.S. Food and Drug Administration for FCX-007

On July 20, 2015, Fibrocell Science, Inc. announced, among other things, that it had submitted an Investigation New Drug Application with the U.S. Food and Drug Administration for FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). Fibrocell expects to initiate a Phase I/II clinical trial by the end of 2015 to evaluate the safety, mechanism of action, and efficacy of FCX-007 for the treatment of RDEB. Also on July 20, 2015, Fibrocell reported positive proof-of-concept data from in vivo pre-clinical studies of FCX-007 that showed: the presence of COL7 in the dermal-epidermal junction of the RDEB cultured grafts in RDEB human skin xenograft severe combined immunodeficiency (SCID) mice; and no apparent systemic distribution of the vector in normal human skin xenograft SCID mice.

Fibrocell Science, Inc.(NasdaqCM:FCSC) added to Russell 2000 Index

Fibrocell Science, Inc. will be added to Russell 2000 Index

Fibrocell Science, Inc.(NasdaqCM:FCSC) added to Russell 3000 Index

Fibrocell Science, Inc. will be added to the Russell 3000 Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FCSC:US $6.34 USD -0.03

FCSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FCSC.
View Industry Companies
 

Industry Analysis

FCSC

Industry Average

Valuation FCSC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FIBROCELL SCIENCE INC, please visit www.fibrocellscience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.